UK markets closed

Medicure Inc. (MPH.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
1.0500+0.0500 (+5.00%)
As of 10:30AM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 10.44M
Enterprise value 4.84M
Trailing P/E 3.93
Forward P/E 13.48
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.48
Price/book (mrq)0.51
Enterprise value/revenue 0.22
Enterprise value/EBITDA 4.80

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-9.91%
S&P500 52-week change 323.49%
52-week high 31.8000
52-week low 30.9200
50-day moving average 31.0744
200-day moving average 31.3292

Share statistics

Avg vol (3-month) 32.79k
Avg vol (10-day) 36.72k
Shares outstanding 510.44M
Implied shares outstanding 610.44M
Float 85.26M
% held by insiders 126.68%
% held by institutions 123.10%
Shares short (15 May 2024) 42.69k
Short ratio (15 May 2024) 41.28
Short % of float (15 May 2024) 40.05%
Short % of shares outstanding (15 May 2024) 40.03%
Shares short (prior month 15 Apr 2024) 42.69k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 302 Nov 2012

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.34%
Operating margin (ttm)0.67%

Management effectiveness

Return on assets (ttm)-2.46%
Return on equity (ttm)-5.55%

Income statement

Revenue (ttm)21.76M
Revenue per share (ttm)2.08
Quarterly revenue growth (yoy)1.20%
Gross profit (ttm)N/A
EBITDA 648k
Net income avi to common (ttm)-1.16M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)-82.40%

Balance sheet

Total cash (mrq)6.07M
Total cash per share (mrq)0.58
Total debt (mrq)476k
Total debt/equity (mrq)2.32%
Current ratio (mrq)2.01
Book value per share (mrq)1.91

Cash flow statement

Operating cash flow (ttm)1.77M
Levered free cash flow (ttm)1.87M